Series date: 
10/01/2019 - 7:30am EDT to 12/31/2023 - 8:30am EST

A multidisciplinary team approach to care is fostered through peer-to-peer discussion and collaboration. The team discussion pertaining to diagnosis and treatment includes radiological and pathological findings and immunohistochemical testing to bridge gaps across the continuum of care and enhance the overall quality of patient-centered oncology care.

Neurosurgeons, Neurologists, Interventional Neuroradiologists, Radiation Oncologists, Medical Oncologists, Pathologists, Radiologists, Intensivists, Internal Medicine Physicians, Allied Health Practitioners, Nurses, Pharmacists, Occupational Therapists and all personnel involved in the care of the brain and spine.


•    Improve clinical decision making, clinical outcomes, and patient experience via a multidisciplinary team approach. Group discussion include prospective patient care management, national treatment guidelines, staging, and options and eligibility for genetic testing, clinical research studies, and supportive care services.

•    Develop a comprehensive treatment plan for brain and spine oncology patients leveraging imaging and pathology testing results and meet Commission on Cancer accreditation standards compliance. 

Yazmin Odia, M.D., M.S., FAAN
Chief, Neuro-Oncology
Miami Cancer Institute
Member, Memorial Sloan Kettering Cancer Alliance
Miami, Florida


Yazmin Odia. M.D., faculty for this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentation or discussion will not include off-label or unapproved product usage.

Cris Alegria, Ady L. Lazcano and Elizabeth Zike and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*

*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients

Disclosure Policy and Disclaimer


Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-448262, by the Florida Boards of Medicine and Osteopathic Medicine.  

This activity has also been approved for 1 credit for Nursing, Pharmacy and Occupational Therapy. Baptist Health South Florida CE Broker Provider #50-182.


American Board of Surgery - Maintenance of Certification (MOC) - Accredited CME - Complex General Surgical Oncology

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Successful completion of this course is submitted to specialty boards through the ACCME's PARS system. 

Series location: 
Baptist Hospital
8900 N. Kendall Dr
Miami, FL 33176
United States


Session Date
Neuro Tumor Board 02/04/2021 - 7:30am to 8:30am EST
Neuro Tumor Board 02/11/2021 - 7:30am to 8:30am EST
Neuro Tumor Board 02/18/2021 - 7:30am to 8:30am EST
Neuro Tumor Board 02/25/2021 - 7:30am to 8:30am EST
Neuro Tumor Board 03/04/2021 - 7:30am to 8:30am EST
Neuro Tumor Board 03/11/2021 - 7:30am to 8:30am EST
Neuro Tumor Board 03/18/2021 - 7:30am to 8:30am EDT
Neuro Tumor Board 03/25/2021 - 7:30am to 8:30am EDT
Neuro Tumor Board 04/01/2021 - 7:30am to 8:30am EDT
Neuro Tumor Board 04/08/2021 - 7:30am to 8:30am EDT